Memory alloreactive cytotoxic T cells do not require costimulation for activation in vitro

Immunology and Cell Biology

Volumn 74, Issue 5, 1996, Pages 413-420

  Flynn, Kirsten ^a   Müllbacher, Arno ^a  

^a Australian National University   (Australia)

Author keywords

Alloreactivity; Costimulation; Cytotoxic T cell; Immunological memory

Indexed keywords

ALLOANTIGEN; B7 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CYTOTOXIC T LYMPHOCYTE; FEMALE; IMMUNIZATION; IMMUNOLOGICAL MEMORY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; STEM CELL; VACCINIA VIRUS;

ANIMALIA; VACCINIA; VACCINIA VIRUS;

EID: 0029800836     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1038/icb.1996.71     Document Type: Article

References (48)

1. + cytotoxic T lymphocytes in the absence of exogenous help. J. Exp. Med. 1993; 177: 1791-6.
2. Gardner ID, Blanden RV. The cell-mediated immune response to ectromelia virus infection. II. Secondary response in vitro and kinetics of memory T cell production in vivo. Cell. Immunol. 1976; 22: 283-96.
3. k. Immunogenetics 1978; 7: 551-61.
4. Ashman RB. Persistence of cell-mediated immunity to influenza A virus in mice. Immunology 1982; 47: 165-8.
5. Effros RB, Bennink J, Doherty PC. Characteristics of secondary cytotoxic T cell responses in mice infected with influenza A viruses. Cell. Immunol. 1978; 36: 345-53.
6. Hill AB, Blanden RV, Parrish CR, Müllbacher A. Restimulated memory Tc cells have a higher apparent avidity of interaction with targets than primary virus-immune Tc cells as indicated by anti-CD8 blocking, Immunol. Cell. Biol. 1992; 70: 259-65.
7. Müllbacher A, Tha Hla R. In vivo administration of major histocompatibility complex class I-specific peptides from influenza virus induces specific cytotoxic T cell hyporesponsiveness. Eur. J. Immunol. 1993; 23: 2526-31.
8. Bruno L, Kirberg J, von Boehmer H. On the cellular basis of immunological T cell memory. Immunity 1995; 2: 37-43.
9. Cerottini J-C, MacDonald HR. The cellular basis of T cell memory. Annu. Rev. Immunol. 1989; 7: 77-89.
10. + T cell memory determined by clonal burst size. Nature 1994; 369: 652-4.
11. Maryanski JL, Pala P, Cerottini J-C, MacDonald HR. Antigen recognition by H-2-restricted cytolytic T lymphocytes: inhibition of cytolysis by anti-CD8 monoclonal antibodies depends upon both concentration and primary sequence of peptide antigen. Eur. J. Immunol. 1988; 18: 1863-6.
12. Blanden RV, Kees U, Dunlop MB. In vitro primary induction of cytotoxic T cells against virus-infected syngeneic cells. J. Immunol. Methods 1977; 16: 73-89.
13. Kos FJ, Müllbacher A. Induction of primary anti-viral cytotoxic T cells by in vitro stimulation with short synthetic peptide and interleukin-7. Eur. J. Immunol. 1992; 22: 3183-5.
14. Macatonia SE, Taylor PM, Knight SC, Askonas BA. Primary stimulation by dendritic cells induces antiviral proliferative and cytotoxic T cell responses in vitro. J. Exp. Med. 1989; 169: 1255-64.
15. Nonacs R, Humborg C, Tam JP, Steinman RM. Mechanisms of mouse spleen dendritic cell function in the generation of influenza-specific, cytolytic T lymphocytes. J. Exp. Med. 1992; 176: 519-29.
16. Croft M, Bradley LM, Swain SL. Naive versus memory CD4 T cell response to antigen. Memory cells are less dependent on accessory cell costimulation and can respond to many antigen-presenting cell types including resting B cells. J. Immunol. 1994; 152: 2675-85.
17. June CH, Bluestone JA, Nadler LM, Thompson CB. The B7 and CD28 receptor families. Immunol. Today 1994; 15: 321-31.
18. Azuma M, Cayabyab M, Buck D, Phillips JH, Lanier LL. CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes. J. Exp. Med. 1992; 175: 353-60.
19. Azuma M, Cayabyab M, Phillips JH, Lanier LL. Requirements for CD28-dependent T cell-mediated cytotoxicity. J. Immunol. 1993; 150: 2091-101.
20. Lanicr LL, O'Fallon S, Somaza C et al. CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytotokine production and generation of CTL. J. Immunol. 1995; 154: 97-105.
21. Medawar PB. The behavior and fate of skin autographs and skin homografts in rabbits. J. Anat. 1944; 78: 176.
22. MacDonald HR, Cerottini J-C, Ryser JE et al. Quantitation and cloning of cytolytic T lymphocytes and their precursors. Immunol. Rev. 1980; 51: 93-123.
23. Matzinger P, Bevan MJ. Hypothesis: why do so many lymphocytes respond to major histocompatibility antigens? Cell. Immunol. 1977; 29: 1-5.
24. Bevan MJ. High determinant density may explain the phenomenon of alloreactivity. Immunol. Today 1984; 5: 128-30.
25. b by alloreactive cytotoxic T lymphocytes. Nature. 1989; 341: 749-52.
26. Alexander-Miller MA, Burke K, Koszinowski UH, Hansen TH, Connolly JM. Alloreactive cytotoxic T lymphocytes generated in the presence of viral-derived peptides show exquisite peptide and MHC specificity. J. Immunol. 1993; 151: 1-10.
27. Müllbacher A, Hill AB, Blanden RV, Cowden WB, King NJ, Tha Hla R. Alloreactive cytotoxic T cells recognize MHC class I antigen without peptide specificity. J. Immunol. 1991; 147: 1765-72.
28. Bluestone JA, Kaliyaperumal A, Jameson S, Miller S, Dick RI. Peptide-induced changes in class I heavy chains alter allorecognition. J. Immunol. 1993; 151: 3943-53.
29. Chattopadhyay S, Theobald M, Biggs J, Sherman LA. Conformational differences in major histocompatibility complex-peptide complexes can result in alloreactivity. J. Exp. Med. 1994; 179: 213-9.
30. Elliott TJ, Eisen HN. Cytotoxic T lymphocytes recognize a reconstituted class I histocompatibility antigen (HLA-A2) as an allogeneic target molecule. Proc. Natl Acad. Sci. USA 1990; 87: 5213-17.
31. Rötzschke O, Falk K, Faath S, Rammensee HG. On the nature of peptides involved in T cell alloreactivity. J. Exp. Med. 1991; 174: 1059-71.
32. Lombardi G, Sidhu S, Daly M, Batchelor JR, Makgoba W, Lechler RI. Are primary alloresponses truly primary? Int. Immunol. 1990; 2: 9-13.
33. Matzinger P. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 1994; 12: 991-1045.
34. d antigen expressed by recombinant vaccinia virus. Proc. Natl Acad. Sci. USA 1986; 83: 7879-82.
35. Karupiah G, Coupar BE, Andrew ME et al. Elevated natural killer cell responses in mice infected with recombinant vaccinia virus encoding murine IL-2. J. Immunol. 1990; 144: 290-8.
36. Zinkernagel RM. Antiviral T-cell memory. In: Gray D, Sprent J. (eds) Current Topics in Microbiology and Immunology. Berlin, Springer-Verlag, 1988; 65-77.
37. Burnet FM. The clonal selection theory of acquired immunity. Cambridge, MA: Cambridge Univ. Press, 1959.
38. Cerottini J-C, Brunner KT. Cell-mediated cytotoxicity, allograft rejection, and tumour immunity. Adv. Immunol. 1974; 18: 67-133.
39. Müllbacher A. The long-term maintenance of cytotoxic T cell memory does not require persistence of antigen. J. Exp. Med. 1994; 179: 317-21.
40. Lau LL, Jamieson BD, Somasundaram T, Ahmed R. Cytotoxic T cell memory without antigen. Nature 1994; 369: 648-52.
41. Fuchs EJ, Matzinger P. B cells turn off virgin but not memory T cells. Science 1992; 258: 1156-9.
42. Brunner KT, Mauel J, Rudolf H, Chapuis B. Studies of allograft immunity in mice. I, Induction, development and in vitro assay of cellular immunity. Immunology 1970; 18: 501-15.
43. Kos FJ, Müllbacher A. IL-2-independent activity of IL-7 in the generation of secondary antigen-specific cytotoxic T cell responses in vitro. J. Immunol. 1993; 150: 387-93.
44. Mitchison NA. Regulatory T lymphocytes. In: Pernis B. & Vogel HJ. (eds) New York, Academic Press, 1980; 147-57.
45. Tough DF, Sprent J. Turnover of naive- and memoryphenotype T cells. J. Exp. Med. 1994; 179: 1127-35.
46. Sprent J, Tough DF. Lymphocyte life-span and memory. Science 1994; 265: 1395-400.
47. Razvi ES, Welsh RM, McFarland HI. In vivo state of antiviral CTL precursors. J. Immunol. 1995; 154: 620-32.
48. Zheng B, Xue W, Kelsoe G. Locus-specific somatic hypermutation in germinal centre T cells. Nature 1994; 372: 556-9.